Class information for:
Level 1: LEVOSIMENDAN//CALCIUM SENSITIZERS//CALCIUM SENSITIZER

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
10578 985 35.3 81%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1446 7310 LEVOSIMENDAN//CALCIUM SENSITIZERS//CALCIUM SENSITIZER

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 LEVOSIMENDAN Author keyword 485 76% 35% 344
2 CALCIUM SENSITIZERS Author keyword 89 92% 4% 35
3 CALCIUM SENSITIZER Author keyword 78 81% 5% 47
4 CA2 SENSITIZER Author keyword 55 87% 3% 27
5 MCI 154 Author keyword 49 94% 2% 17
6 PIMOBENDAN Author keyword 48 65% 5% 45
7 EMD 57033 Author keyword 25 77% 2% 17
8 EMD 53998 Author keyword 21 85% 1% 11
9 OR 1896 Author keyword 18 89% 1% 8
10 SIMENDAN Author keyword 18 89% 1% 8

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 LEVOSIMENDAN 485 76% 35% 344 Search LEVOSIMENDAN Search LEVOSIMENDAN
2 CALCIUM SENSITIZERS 89 92% 4% 35 Search CALCIUM+SENSITIZERS Search CALCIUM+SENSITIZERS
3 CALCIUM SENSITIZER 78 81% 5% 47 Search CALCIUM+SENSITIZER Search CALCIUM+SENSITIZER
4 CA2 SENSITIZER 55 87% 3% 27 Search CA2+SENSITIZER Search CA2+SENSITIZER
5 MCI 154 49 94% 2% 17 Search MCI+154 Search MCI+154
6 PIMOBENDAN 48 65% 5% 45 Search PIMOBENDAN Search PIMOBENDAN
7 EMD 57033 25 77% 2% 17 Search EMD+57033 Search EMD+57033
8 EMD 53998 21 85% 1% 11 Search EMD+53998 Search EMD+53998
9 OR 1896 18 89% 1% 8 Search OR+1896 Search OR+1896
10 SIMENDAN 18 89% 1% 8 Search SIMENDAN Search SIMENDAN

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CALCIUM SENSITIZER 327 85% 18% 175
2 INTRAVENOUS LEVOSIMENDAN 187 86% 10% 96
3 CA2 SENSITIZER 151 91% 6% 62
4 CALCIUM SENSITIZER LEVOSIMENDAN 150 96% 5% 47
5 EMD 53998 94 94% 3% 33
6 CARDIAC TROPONIN C 72 51% 10% 101
7 MEDIATED CALCIUM SENSITIZATION 47 88% 2% 22
8 CARDIOTONIC AGENT 46 44% 8% 78
9 MCI 154 27 92% 1% 11
10 PIMOBENDAN 25 44% 4% 43

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Effects of levosimendan for low cardiac output syndrome in critically ill patients: systematic review with meta-analysis and trial sequential analysis 2015 3 60 68%
Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies 2012 48 90 84%
Levosimendan: Molecular mechanisms and clinical implications Consensus of experts on the mechanisms of action of levosimendan 2012 24 92 87%
Preoperative and perioperative use of levosimendan in cardiac surgery: European expert opinion 2015 1 63 81%
A Bayesian network meta-analysis on the effect of inodilatory agents on mortality 2015 1 45 62%
Perioperative Use of Levosimendan: Best Practice in Operative Settings 2013 6 54 91%
Pharmacology of levosimendan: inotropic, vasodilatory and cardioprotective effects 2013 7 81 72%
Intermittent levosimendan improves mid-term survival in chronic heart failure patients: meta-analysis of randomised trials 2014 4 41 68%
Levosimendan reduces mortality in critically ill patients. A meta-analysis of randomized controlled studies 2010 27 35 74%
Evidence-based use of levosimendan in different clinical settings 2006 64 64 83%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 CARDIOVASC PROJECTS 8 100% 0.5% 5
2 CARDIOTHORAC ANAESTHESIA INTENS CARE UNIT 4 75% 0.3% 3
3 PHYSIOL EXPT SURG 3 60% 0.3% 3
4 STRAZHESKO CARDIOL 3 60% 0.3% 3
5 KLINIKUM WEIDEN 2 67% 0.2% 2
6 OFF HAL 18 D2 2 67% 0.2% 2
7 DRUG DISCOVERY PHARMACOL 2 40% 0.4% 4
8 CARDIOVASC CRIT CARE 2 36% 0.4% 4
9 ANAESTHESIA INTENS CAREUMR 942 1 100% 0.2% 2
10 ANESTHESIOL SCI CRIT MED PAIN THER Y 1 100% 0.2% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000226742 ENOXIMONE//AMRINONE//MILRINONE
2 0.0000158349 BDF 9148//DPI 201 106//NA CHANNEL MODULATORS
3 0.0000114911 TSC 22//VESNARINONE//POSITIVE INOTROPIC ACTIVITY
4 0.0000102334 NESIRITIDE//ACUTE HEART FAILURE//CARDIORENAL SYNDROME
5 0.0000059077 TROPONIN C//TROPONIN//TROPOMYOSIN
6 0.0000054278 FORCE FREQUENCY RELATIONSHIP//FORCE FREQUENCY RELATION//D DAVIS HEART LUNG
7 0.0000051599 PRESSURE VOLUME AREA//CONDUCTANCE CATHETER//END SYSTOLIC PRESSURE VOLUME RELATION
8 0.0000048473 VASODILATORY SHOCK//VASOPLEGIC SYNDROME//VASOPLEGIA
9 0.0000047324 UNITE CARDIOL ALFORT//UNITE PHARM TOXICOL//JOURNAL OF VETERINARY CARDIOLOGY
10 0.0000046094 SEPTIC CARDIOMYOPATHY//CARDIONOME//MYOCARDIAL DEPRESSION